NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,448 | -2.6% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $1,486 | -75.2% | 200 | -76.9% | 0.00% | -100.0% |
| Q1 2023 | $5,994 | -32.6% | 865 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,892 | -44.4% | 865 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $16,000 | -63.6% | 865 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $44,000 | -31.2% | 865 | 0.0% | 0.01% | -20.0% |
| Q1 2022 | $64,000 | -48.8% | 865 | -0.7% | 0.01% | -50.0% |
| Q4 2021 | $125,000 | -22.4% | 871 | +12.2% | 0.02% | -37.5% |
| Q3 2021 | $161,000 | -2.4% | 776 | 0.0% | 0.03% | -15.8% |
| Q2 2021 | $165,000 | +50.0% | 776 | +28.5% | 0.04% | +18.8% |
| Q1 2021 | $110,000 | +223.5% | 604 | +98.0% | 0.03% | +166.7% |
| Q4 2020 | $34,000 | +1033.3% | 305 | +1.7% | 0.01% | +1100.0% |
| Q3 2020 | $3,000 | +200.0% | 300 | +631.7% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |